EN | 中文
Novast Laboratories

With highly experienced management made of international team members who had achieved over 90 approvals from the U.S. FDA in past roles, Novast Laboratories has become China first and only pharmaceutical company to gain U.S. FDA approval for its finished drugs and place them on the U.S. market. Novast operates with a culture surrounded by highest quality systems and standards and competes on the marketplace on a basis of the quality of its improved specialty generic drugs. The company has a total of 20 products successfully launched in the U.S. market.